GOLDMAN MYLA LAI Insider Trading $LH LABORATORY CORP OF AMERICA HOLDINGS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GOLDMAN MYLA LAI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GOLDMAN MYLA LAI. GOLDMAN MYLA LAI is EVP & Chief Medical Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
GOLDMAN MYLA LAI in LABORATORY CORP OF AMERICA HOLDINGS
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of GOLDMAN MYLA LAI: EVP & Chief Medical Officer
Holdings: 22,660 shares
Current Value: $2,942,628
Latest Transaction: May 09 2008
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GOLDMAN MYLA LAI in LABORATORY CORP OF AMERICA HOLDINGS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 10,300 | 824,000 | 39,637 | 49.9 K to 39.6 K (-20.63 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 10,300 | 401,700 | 49,937 | 39.6 K to 49.9 K (+25.99 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 6,500 | 253,500 | 0 | |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 10,300 | 401,700 | 6,500 | |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 4,100 | 0 | 43,737 | 39.6 K to 43.7 K (+10.34 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 6,500 | 520,000 | 39,637 | 46.1 K to 39.6 K (-14.09 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 6,500 | 253,500 | 46,137 | 39.6 K to 46.1 K (+16.40 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 10,300 | 824,000 | 39,637 | 49.9 K to 39.6 K (-20.63 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 10,300 | 401,700 | 49,937 | 39.6 K to 49.9 K (+25.99 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 6,500 | 253,500 | 0 | |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 10,300 | 401,700 | 6,500 | |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 4,100 | 0 | 43,737 | 39.6 K to 43.7 K (+10.34 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 6,500 | 520,000 | 39,637 | 46.1 K to 39.6 K (-14.09 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 6,500 | 253,500 | 46,137 | 39.6 K to 46.1 K (+16.40 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 80.00 | 10,300 | 824,000 | 39,637 | 49.9 K to 39.6 K (-20.63 %) |
| Feb 14 2008 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 39.00 | 10,300 | 401,700 | 49,937 | 39.6 K to 49.9 K (+25.99 %) |
| Mar 05 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 79.68 | 909 | 72,429 | 40,299 | 41.2 K to 40.3 K (-2.21 %) |
| Feb 27 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 80.25 | 909 | 72,947 | 41,208 | 42.1 K to 41.2 K (-2.16 %) |
| Feb 22 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | A | 80.37 | 30,000 | 2,411,100 | 30,000 | |
| Feb 22 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 8,400 | 0 | 42,117 | 33.7 K to 42.1 K (+24.91 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.00 | 310 | 22,630 | 33,717 | 34 K to 33.7 K (-0.91 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.06 | 155 | 11,324 | 34,027 | 34.2 K to 34 K (-0.45 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.07 | 155 | 11,326 | 34,182 | 34.3 K to 34.2 K (-0.45 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.10 | 156 | 11,404 | 34,337 | 34.5 K to 34.3 K (-0.45 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.12 | 158 | 11,553 | 34,493 | 34.7 K to 34.5 K (-0.46 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.15 | 156 | 11,411 | 34,651 | 34.8 K to 34.7 K (-0.45 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.16 | 156 | 11,413 | 34,807 | 35 K to 34.8 K (-0.45 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.25 | 155 | 11,354 | 34,963 | 35.1 K to 35 K (-0.44 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 73.50 | 155 | 11,393 | 35,118 | 35.3 K to 35.1 K (-0.44 %) |
| Feb 07 2007 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 73.53 | 830 | 61,030 | 35,273 | 36.1 K to 35.3 K (-2.30 %) |
| Jul 14 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 47.89 | 10,000 | 478,900 | 20,000 | |
| Jul 14 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 63.00 | 10,000 | 630,000 | 35,642 | 45.6 K to 35.6 K (-21.91 %) |
| Jul 14 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 47.89 | 10,000 | 478,900 | 45,642 | 35.6 K to 45.6 K (+28.06 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 43.53 | 49,719 | 2,164,268 | 0 | |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.00 | 47,047 | 2,822,820 | 35,642 | 82.7 K to 35.6 K (-56.90 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.10 | 965 | 57,997 | 82,689 | 83.7 K to 82.7 K (-1.15 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.13 | 74 | 4,450 | 83,654 | 83.7 K to 83.7 K (-0.09 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.15 | 520 | 31,278 | 83,728 | 84.2 K to 83.7 K (-0.62 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.17 | 74 | 4,453 | 84,248 | 84.3 K to 84.2 K (-0.09 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.18 | 148 | 8,907 | 84,322 | 84.5 K to 84.3 K (-0.18 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.19 | 594 | 35,753 | 84,470 | 85.1 K to 84.5 K (-0.70 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.20 | 297 | 17,879 | 85,064 | 85.4 K to 85.1 K (-0.35 %) |
| May 19 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 43.53 | 49,719 | 2,164,268 | 85,361 | 35.6 K to 85.4 K (+139.50 %) |
| Apr 20 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 43.53 | 681 | 29,644 | 49,719 | |
| Apr 20 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 60.00 | 681 | 40,860 | 35,642 | 36.3 K to 35.6 K (-1.87 %) |
| Apr 20 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 43.53 | 681 | 29,644 | 36,323 | 35.6 K to 36.3 K (+1.91 %) |
| Mar 03 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.80 | 328 | 18,958 | 35,642 | 36 K to 35.6 K (-0.91 %) |
| Mar 03 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.91 | 253 | 14,651 | 35,970 | 36.2 K to 36 K (-0.70 %) |
| Mar 03 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.00 | 757 | 43,906 | 36,223 | 37 K to 36.2 K (-2.05 %) |
| Mar 03 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.11 | 273 | 15,864 | 36,980 | 37.3 K to 37 K (-0.73 %) |
| Mar 03 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Payment of Exercise | F | 58.11 | 1,189 | 69,093 | 37,253 | 38.4 K to 37.3 K (-3.09 %) |
| Feb 27 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | A | 58.57 | 30,000 | 1,757,100 | 30,000 | |
| Feb 27 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Grant | A | 0.00 | 8,400 | 0 | 38,442 | 30 K to 38.4 K (+27.96 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.82 | 332 | 19,196 | 32,215 | 32.5 K to 32.2 K (-1.02 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.83 | 9 | 520 | 32,547 | 32.6 K to 32.5 K (-0.03 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.84 | 18 | 1,041 | 32,556 | 32.6 K to 32.6 K (-0.06 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.85 | 238 | 13,768 | 32,574 | 32.8 K to 32.6 K (-0.73 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.86 | 217 | 12,556 | 32,812 | 33 K to 32.8 K (-0.66 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.87 | 387 | 22,396 | 33,029 | 33.4 K to 33 K (-1.16 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.88 | 238 | 13,775 | 33,416 | 33.7 K to 33.4 K (-0.71 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.89 | 428 | 24,777 | 33,654 | 34.1 K to 33.7 K (-1.26 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.90 | 522 | 30,224 | 34,082 | 34.6 K to 34.1 K (-1.51 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.91 | 607 | 35,151 | 34,604 | 35.2 K to 34.6 K (-1.72 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.94 | 76 | 4,403 | 35,211 | 35.3 K to 35.2 K (-0.22 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.95 | 132 | 7,649 | 35,287 | 35.4 K to 35.3 K (-0.37 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.97 | 578 | 33,507 | 35,419 | 36 K to 35.4 K (-1.61 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.98 | 199 | 11,538 | 35,997 | 36.2 K to 36 K (-0.55 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.99 | 76 | 4,407 | 36,196 | 36.3 K to 36.2 K (-0.21 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.00 | 2,676 | 155,208 | 36,272 | 38.9 K to 36.3 K (-6.87 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.01 | 930 | 53,949 | 38,948 | 39.9 K to 38.9 K (-2.33 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.02 | 143 | 8,297 | 39,878 | 40 K to 39.9 K (-0.36 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.03 | 67 | 3,888 | 40,021 | 40.1 K to 40 K (-0.17 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.04 | 228 | 13,233 | 40,088 | 40.3 K to 40.1 K (-0.57 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.05 | 105 | 6,095 | 40,316 | 40.4 K to 40.3 K (-0.26 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.06 | 303 | 17,592 | 40,421 | 40.7 K to 40.4 K (-0.74 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.07 | 171 | 9,930 | 40,724 | 40.9 K to 40.7 K (-0.42 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.08 | 47 | 2,730 | 40,895 | 40.9 K to 40.9 K (-0.11 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.09 | 208 | 12,083 | 40,942 | 41.2 K to 40.9 K (-0.51 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.10 | 56 | 3,254 | 41,150 | 41.2 K to 41.2 K (-0.14 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.11 | 357 | 20,745 | 41,206 | 41.6 K to 41.2 K (-0.86 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.13 | 484 | 28,135 | 41,563 | 42 K to 41.6 K (-1.15 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.50 | 711 | 40,883 | 30,042 | 30.8 K to 30 K (-2.31 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.55 | 47 | 2,705 | 30,753 | 30.8 K to 30.8 K (-0.15 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.70 | 190 | 10,963 | 30,800 | 31 K to 30.8 K (-0.61 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.74 | 230 | 13,280 | 30,990 | 31.2 K to 31 K (-0.74 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.77 | 123 | 7,106 | 31,220 | 31.3 K to 31.2 K (-0.39 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.79 | 123 | 7,108 | 31,343 | 31.5 K to 31.3 K (-0.39 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.80 | 94 | 5,433 | 31,466 | 31.6 K to 31.5 K (-0.30 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 57.81 | 380 | 21,968 | 31,560 | 31.9 K to 31.6 K (-1.19 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.12 | 275 | 15,983 | 31,940 | 32.2 K to 31.9 K (-0.85 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 24.46 | 16,800 | 410,928 | 0 | |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.14 | 352 | 20,465 | 42,047 | 42.4 K to 42 K (-0.83 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.15 | 133 | 7,734 | 42,399 | 42.5 K to 42.4 K (-0.31 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.16 | 38 | 2,210 | 42,532 | 42.6 K to 42.5 K (-0.09 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.17 | 9 | 524 | 42,570 | 42.6 K to 42.6 K (-0.02 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.18 | 152 | 8,843 | 42,579 | 42.7 K to 42.6 K (-0.36 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.19 | 70 | 4,073 | 42,731 | 42.8 K to 42.7 K (-0.16 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.20 | 323 | 18,799 | 42,801 | 43.1 K to 42.8 K (-0.75 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.21 | 683 | 39,757 | 43,124 | 43.8 K to 43.1 K (-1.56 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.22 | 76 | 4,425 | 43,807 | 43.9 K to 43.8 K (-0.17 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.24 | 38 | 2,213 | 43,883 | 43.9 K to 43.9 K (-0.09 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.25 | 900 | 52,425 | 43,921 | 44.8 K to 43.9 K (-2.01 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.26 | 295 | 17,187 | 44,821 | 45.1 K to 44.8 K (-0.65 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.27 | 56 | 3,263 | 45,116 | 45.2 K to 45.1 K (-0.12 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.28 | 209 | 12,181 | 45,172 | 45.4 K to 45.2 K (-0.46 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.29 | 104 | 6,062 | 45,381 | 45.5 K to 45.4 K (-0.23 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.30 | 47 | 2,740 | 45,485 | 45.5 K to 45.5 K (-0.10 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.35 | 379 | 22,115 | 45,532 | 45.9 K to 45.5 K (-0.83 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.37 | 114 | 6,654 | 45,911 | 46 K to 45.9 K (-0.25 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.38 | 76 | 4,437 | 46,025 | 46.1 K to 46 K (-0.16 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.39 | 105 | 6,131 | 46,101 | 46.2 K to 46.1 K (-0.23 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.40 | 142 | 8,293 | 46,206 | 46.3 K to 46.2 K (-0.31 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.41 | 57 | 3,329 | 46,348 | 46.4 K to 46.3 K (-0.12 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.42 | 19 | 1,110 | 46,405 | 46.4 K to 46.4 K (-0.04 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.43 | 57 | 3,331 | 46,424 | 46.5 K to 46.4 K (-0.12 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.44 | 180 | 10,519 | 46,481 | 46.7 K to 46.5 K (-0.39 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.45 | 58 | 3,390 | 46,661 | 46.7 K to 46.7 K (-0.12 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.46 | 76 | 4,443 | 46,719 | 46.8 K to 46.7 K (-0.16 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Buy | M | 24.46 | 16,800 | 410,928 | 46,842 | 30 K to 46.8 K (+55.92 %) |
| Feb 23 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.50 | 47 | 2,750 | 46,795 | 46.8 K to 46.8 K (-0.10 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.01 | 519 | 30,107 | 30,042 | 30.6 K to 30 K (-1.70 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.02 | 97 | 5,628 | 30,561 | 30.7 K to 30.6 K (-0.32 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.04 | 324 | 18,805 | 30,658 | 31 K to 30.7 K (-1.05 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.06 | 357 | 20,727 | 30,982 | 31.3 K to 31 K (-1.14 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.07 | 324 | 18,815 | 31,339 | 31.7 K to 31.3 K (-1.02 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.08 | 162 | 9,409 | 31,663 | 31.8 K to 31.7 K (-0.51 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.09 | 29 | 1,685 | 31,825 | 31.9 K to 31.8 K (-0.09 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.10 | 292 | 16,965 | 31,854 | 32.1 K to 31.9 K (-0.91 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Option Exercise | M | 39.00 | 16,800 | 655,200 | 16,800 | |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.11 | 811 | 47,127 | 32,146 | 33 K to 32.1 K (-2.46 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.14 | 551 | 32,035 | 32,957 | 33.5 K to 33 K (-1.64 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.16 | 292 | 16,983 | 33,508 | 33.8 K to 33.5 K (-0.86 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.17 | 328 | 19,080 | 33,800 | 34.1 K to 33.8 K (-0.96 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.20 | 908 | 52,846 | 34,128 | 35 K to 34.1 K (-2.59 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.21 | 842 | 49,013 | 35,036 | 35.9 K to 35 K (-2.35 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.22 | 1,004 | 58,453 | 35,878 | 36.9 K to 35.9 K (-2.72 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.24 | 812 | 47,291 | 36,882 | 37.7 K to 36.9 K (-2.15 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.25 | 260 | 15,145 | 37,694 | 38 K to 37.7 K (-0.69 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.26 | 195 | 11,361 | 37,954 | 38.1 K to 38 K (-0.51 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.27 | 941 | 54,832 | 38,149 | 39.1 K to 38.1 K (-2.41 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.28 | 32 | 1,865 | 39,090 | 39.1 K to 39.1 K (-0.08 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.29 | 1 | 58 | 39,122 | 39.1 K to 39.1 K (0.00 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.31 | 681 | 39,709 | 39,123 | 39.8 K to 39.1 K (-1.71 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.33 | 714 | 41,648 | 39,804 | 40.5 K to 39.8 K (-1.76 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.35 | 292 | 17,038 | 40,518 | 40.8 K to 40.5 K (-0.72 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.38 | 357 | 20,842 | 40,810 | 41.2 K to 40.8 K (-0.87 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.39 | 908 | 53,018 | 41,167 | 42.1 K to 41.2 K (-2.16 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.40 | 389 | 22,718 | 42,075 | 42.5 K to 42.1 K (-0.92 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.41 | 519 | 30,315 | 42,464 | 43 K to 42.5 K (-1.21 %) |
| Feb 22 2006 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP & Chief Medical ... | Sell | S | 58.42 | 259 | 15,131 | 42,983 | 43.2 K to 43 K (-0.60 %) |